Workflow
智慧医疗
icon
Search documents
以智慧城市建设推动加快形成新质生产力
Jin Rong Shi Bao· 2026-01-12 03:57
Core Viewpoint - The development of new quality productivity is an intrinsic requirement and important focus for promoting high-quality development in China, with smart city construction serving as a strategic pivot for this transformation [1]. Group 1: Smart City Construction as a Strategic Choice - Smart city construction is a practical carrier that adapts to the transformation of production methods, fundamentally reshaping urban governance through the integration of digital technologies [2]. - The Chinese government has been promoting smart city construction since 2016, emphasizing data-driven and people-centered approaches to optimize governance and resource integration [2]. - Smart cities enhance the efficiency of production factor allocation and are essential for optimizing urban functions and driving productivity growth [3]. Group 2: Goals of Smart City Construction - Smart cities represent a direct integration of advanced productivity, providing an environment for the reconfiguration of key production factors such as technology, capital, talent, and data [3]. - The urbanization rate in China has increased from 17.9% in 1978 to 66.2% in 2023, highlighting the need for smart city initiatives to address challenges like resource efficiency and environmental pressures [3]. - Empirical studies indicate that doubling urban scale can increase total factor productivity by 3.5% to 8%, with smart city initiatives potentially amplifying this effect [3]. Group 3: Government's Role in Smart City Development - Smart city construction is recognized globally as a core pathway for urban modernization, with various international initiatives emphasizing the importance of technology and management innovation [4][5]. - China has over 500 smart city pilot projects covering more than 95% of prefecture-level cities, indicating a strong governmental commitment to enhancing urban governance through digital platforms [5]. - The government plays a crucial role in guiding multi-stakeholder participation, ensuring effective alignment between technological innovation and urban needs [5]. Group 4: Value Orientation of Smart Cities - The concept of a "people's city" aligns with the people-centered philosophy of new quality productivity, emphasizing the active role of citizens in urban governance [6]. - Smart city initiatives have shifted from traditional monitoring models to collaborative governance, involving government, enterprises, and citizens in decision-making processes [6]. - The focus on human-centered values in smart city construction reflects the broader goal of meeting the growing needs of the population for a better quality of life [6]. Group 5: Key Focus Areas for Developing New Quality Productivity - Strengthening technological innovation is essential for enhancing the foundational capabilities of smart cities and fostering strategic emerging industries [7]. - Establishing a comprehensive digital transformation framework is necessary to support the development of smart cities, including investments in new infrastructure and optimizing regulatory arrangements [8]. - Improving urban governance through data-driven models and enhancing public service accessibility are critical for expanding the market for new quality productivity [9]. Group 6: Sustainable Development and Ecological Civilization - Promoting smart environmental practices and green industries is vital for effective resource management and environmental risk mitigation [10]. - Efficient utilization of resources and energy through smart technologies is essential for sustainable urban development [10]. - Encouraging eco-friendly lifestyles through smart city initiatives can enhance public engagement in sustainability efforts [10]. Group 7: Coordinating Development and Integration - Deepening the reform of smart city systems in alignment with national strategies is crucial for balancing new quality productivity and production relationships [11]. - Promoting regional integration and urban-rural development through smart city platforms can facilitate efficient resource allocation and governance [11]. - Establishing a long-term mechanism for public services and social security is necessary to address challenges such as population aging and economic restructuring [11].
AI应用产品登上“科技春晚”,最牛股志特新材20CM五连板|透视一周牛熊股
过去一周(1月5日—1月9日),三大股指集体上涨。截至1月9日收盘,上证指数周涨幅3.82%,报点4120.43,创下10年新高;深证成指周涨幅4.40%,报 14120.15点;创业板指周涨幅3.89%,报3327.81点。 具体来看,超86%的个股周内实现上涨,488股周涨超15%,仅7股跌幅超15%。按申万二级行业分类,航天装备Ⅱ、风电设备、广告营销等板块涨幅居前, 国有大型银行Ⅱ、股份制银行Ⅱ、航空机场等板块跌幅居前。 哪些个股领涨?哪些个股领跌?21投资通每周持续为你透视。 (图源:wind金融终端) 行业消息面上,近期AI应用板块迎来密集利好消息。 日前,Meta正式宣布收购AI智能体公司Manus,收购金额或高达数十亿美元,成为Meta成立以来第三大收购。 值得注意的是,商务部新闻发言人何亚东1月8日在回应有关审查Meta收购人工智能平台Manus的提问时表示,企业从事对外投资、技术出口、数据出 境、跨境并购等活动,须符合中国法律法规,履行法定程序。 在国内政策方面,近日工信部等八部门印发《"人工智能+制造"专项行动实施意见》,明确以推动信息化和工业化深度融合为主线,推动"人工智能(AI) +" ...
创业慧康:公司将持续关注新兴医疗健康应用场景的市场机遇
证券日报网讯 1月8日,创业慧康在互动平台回答投资者提问时表示,公司专注于医疗卫生健康信息化 的建设、研发及服务创新,产品涵盖智慧医疗、智慧卫生、医保、健康及养老等各种智慧场景。公司将 持续关注新兴医疗健康应用场景的市场机遇,若未来脑机接口等新应用场景在医疗行业逐步显现,公司 将依托现有技术积累与战略发展规划,及时跟进并积极探索拓展相关产品应用边界。 (编辑 丛可心) ...
创业慧康:将依托现有技术积累,及时跟进并积极探索拓展脑机接口等新应用场景
Sou Hu Cai Jing· 2026-01-08 07:58
有投资者在互动平台向创业慧康提问:"公司是否储备脑机接口技术?" 声明:市场有风险,投资需谨慎。本文为AI基于第三方数据生成,仅供参考,不构成个人投资建议。 来源:市场资讯 针对上述提问,创业慧康回应称:"尊敬的投资者,您好!公司专注于医疗卫生健康信息化的建设、研 发及服务创新,产品涵盖智慧医疗、智慧卫生、医保、健康及养老等各种智慧场景。公司将持续关注新 兴医疗健康应用场景的市场机遇,若未来脑机接口等新应用场景在医疗行业逐步显现,公司将依托现有 技术积累与战略发展规划,及时跟进并积极探索拓展相关产品应用边界。感谢您的关注!" ...
创业慧康:将依托现有技术积累探索脑机接口应用
Sou Hu Cai Jing· 2026-01-08 07:40
以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成 投资建议。 创业慧康回复:尊敬的投资者,您好!公司专注于医疗卫生健康信息化的建设、研发及服务创新,产品 涵盖智慧医疗、智慧卫生、医保、健康及养老等各种智慧场景。公司将持续关注新兴医疗健康应用场景 的市场机遇,若未来脑机接口等新应用场景在医疗行业逐步显现,公司将依托现有技术积累与战略发展 规划,及时跟进并积极探索拓展相关产品应用边界。感谢您的关注! 证券之星消息,创业慧康(300451)01月08日在投资者关系平台上答复投资者关心的问题。 投资者提问:公司是否储备脑机接口技术? ...
京杭沪位列“最健康城市”前三,多地启动健康促进立法工作
Di Yi Cai Jing· 2025-12-23 12:37
Core Insights - The report titled "Tsinghua Urban Health Index 2025" highlights the health index rankings of cities in China, with Beijing, Hangzhou, Shanghai, Nanjing, and Xiamen leading in large cities, while Huzhou, Jinhua, and Quzhou dominate in smaller cities [1][3] Group 1: Health Index Rankings - In the large city category, Beijing, Hangzhou, Shanghai, Nanjing, and Xiamen are ranked as the top five cities in the health index [3] - In the small city category, Zhejiang province claims the top three spots with Huzhou, Jinhua, and Quzhou [3] Group 2: Health Services and Government Role - The report indicates that Beijing ranks first in health services, industry, and behavior among major cities, while Shanghai and Nanjing are the only two cities with all five major indicators in the top five [5] - Government initiatives have been identified as key drivers in improving urban health levels, particularly in health service indicators [5] Group 3: Regional Advantages - The report notes that different regions have distinct advantages, with the Beijing-Tianjin-Hebei region having high-level medical resources and the Pearl River Delta exhibiting a dual-driven development in health industry and behavior [6] - The Yangtze River Delta region shows balanced leadership across all six evaluation categories, particularly excelling in new drug research and health utility indices [6] Group 4: Health Behavior and Legislative Efforts - Health behavior is a critical factor affecting both health utility and the development of the health industry, with current scores being generally low across cities [8] - Local legislative efforts, such as the "Hangzhou Health Promotion Regulation," aim to establish health impact assessments for public policies and projects [8] Group 5: Medical Informationization and Health Expenditure - The report emphasizes the importance of medical informationization, noting that the domestic market has exceeded 20 billion yuan, with significant concentration in major cities [9] - Health expenditure is highlighted as a key indicator of health behavior, with sports events positively influencing consumer spending and health behavior improvements [9]
欧普康视:尚未应用智慧医疗
Mei Ri Jing Ji Xin Wen· 2025-12-23 01:07
每经AI快讯,有投资者在投资者互动平台提问:请介绍尚悦启程医院管理有限公司在AI医疗、智慧医 疗、未来公司发展布局。 欧普康视(300595.SZ)12月23日在投资者互动平台表示,尚未应用智慧医疗。 (记者 胡玲) ...
思创医惠:12月12日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-12-12 11:24
每经AI快讯,思创医惠(SZ 300078,收盘价:4.25元)12月12日晚间发布公告称,公司第六届第十五 次董事会会议于2025年12月12日在公司会议室以通讯表决的方式召开。会议审议了《关于2026年度日常 关联交易预计的议案》等文件。 2025年1至6月份,思创医惠的营业收入构成为:出售房产占比53.84%,商业智能占比39.28%,智慧医 疗占比6.87%。 每经头条(nbdtoutiao)——实施城乡居民增收计划、降准降息等工具灵活高效运用、增加普通高中学 位……深度解读中央经济工作会议 (记者 张明双) 截至发稿,思创医惠市值为48亿元。 ...
智能系统与产业创新应用分论坛在新国大广州创新研究院举办
论坛伊始,广州市科学技术局副局长吴汉荣先生致开幕辞。他指出,广州正全力推进粤港澳大湾区国际科技创新中心建设,紧紧围绕科技创新发展全链 条,着力对接国际优质创新资源,已取得一系列国际合作成果,为深化高水平科技交流合作奠定了良好基础。吴汉荣副局长进一步表示,要充分发挥中新 广州知识城等国际合作平台优势,深化政产学研协同,加速推动智能技术在医疗、交通、制造等场景的融合应用,他期待本次论坛能有效促进科技领域的 深入交流与合作,携手推动大湾区产业创新与高质量发展。 随后,新加坡工程院院士、新加坡国立大学广州创新研究院院长葛树志教授在致辞中表示,研究院作为新国大服务粤港澳大湾区的旗舰平台,将持续推动 智能系统领域的国际科研合作与成果落地。他强调,本次论坛旨在打通"技术—产业"转化链路,加速机器人、智慧医疗等前沿应用在湾区开花结果,助力 构建具有全球影响力的智能创新生态。 顶尖学者齐聚 多维洞见赋能创新 本次论坛特别邀请了9位来自新加坡国立大学的顶尖学者——同时也是新国大广州创新研究院学术带头人——开展主题演讲。各位教授围绕基础研究突破 与产业应用实践,分享兼具前瞻性与实践价值的学术洞见及技术成果,覆盖机器人技术、自旋电子 ...
华检医疗“三步走”谋求入主,创业慧康易主背后仍未走出亏损
Xin Jing Bao· 2025-11-27 02:21
Core Viewpoint - The leading medical information technology company, Chuangye Huikang, is set to change ownership as Hangzhou Genghao Investment Management Partnership has initiated a share transfer process, marking a significant shift in control amidst declining performance for both companies [1][8]. Group 1: Ownership Change - Hangzhou Genghao has paid approximately 158 million yuan as the first installment for the share transfer [1]. - The agreement involves Hangzhou Genghao acquiring 9,652,509 shares from the largest shareholder, Ge Hang, representing 6.23% of the total share capital, at a price of 5.18 yuan per share, totaling 500 million yuan [3][4]. - Following the transfer, Hangzhou Genghao's voting rights will increase from 0% to 12.64%, making it the largest shareholder of Chuangye Huikang [4]. Group 2: Financial Performance - Chuangye Huikang has experienced three consecutive years of declining performance, with a reported net loss of 173 million yuan in 2024, marking its first loss since going public [9]. - For the first three quarters of 2025, the company reported a revenue of 862 million yuan, a decrease of 26.26% year-on-year, and a net loss of 122 million yuan, a staggering decline of 331.69% [10]. - Hangzhou Genghao's parent company, Huajian Medical, also reported a decline in performance, with a revenue of 1.27 billion yuan in the first half of 2025, down 6.2%, and a net profit of 38.32 million yuan, down 70% [7][8]. Group 3: Strategic Intent - The acquisition aims to position Chuangye Huikang as a leader in the AI healthcare sector, with plans for board restructuring and potential capital increases to enhance control [5][8]. - Chuangye Huikang, founded in 1997, focuses on medical information services and has seen its market value drop significantly from over 20 billion yuan at its peak [8][10].